It can be classified according to the expression of proteins and genes into Three categories: hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative breast cancer (TNBC) [5]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.